Stuart Naylor, Ph.D.

Dr. Stuart Naylor has served as our Chief Development Officer since April 2015. From April 2015 to April 2016, Dr. Naylor was Chief Executive Officer of Athena Vision, a biotechnology company. From June 2013 to April 2015, Dr. Naylor served as managing director of Coltivare Ltd., a healthcare consulting company. From 2008 to 2013, Dr. Naylor was Executive Director and Chief Scientific Officer of Oxford BioMedica plc, a gene therapy company. Prior to joining Oxford BioMedica, Dr. Naylor focused on translational cancer research at the Institute of Cancer Research. Dr. Naylor has a B.S.C. in microbiology and virology from the University of Warwick, a M.S. in Immunology from Kings College London, and a Ph.D. from the Imperial Cancer Research Fund laboratory studying ovarian cancer and cytokine biology.